Weihua New Material plans to acquire 624,700 shares of Lansheng Biotechnology for 12.087 million yuan
I'm LongbridgeAI, I can summarize articles.Weihua New Material announced that the company plans to jointly invest with related party Wu Jiangwei in Lansheng Biotechnology Group, acquiring 624,700 shares of Lansheng Biotechnology at a transfer price of 12.087 million yuan. Wu Jiangwei will acquire 180,900 shares and 452,300 shares from Pengzhi Venture Capital and Guan Congqiao, respectively, at transfer prices of 3.5 million yuan and 8.75 million yuan. This investment will help enhance the future profitability of the listed company
According to the announcement from Zhitong Finance APP, Weihua New Material (603310.SH) stated that the company plans to jointly invest in Lansheng Biotechnology Group Co., Ltd. (referred to as "Lansheng Biotechnology") with related party Wu Jiangwei. The company intends to acquire 624,700 shares of Lansheng Biotechnology (accounting for 0.6907% of the total share capital of Lansheng Biotechnology) legally held by Shijiazhuang Pengzhi Venture Capital Center (Limited Partnership) (referred to as "Pengzhi Venture Capital") for cash, with a transfer price of 12.087 million yuan. Mr. Wu Jiangwei plans to acquire 180,900 shares and 452,300 shares of Lansheng Biotechnology (accounting for 0.2000% and 0.5000% of the total share capital of Lansheng Biotechnology, respectively) for cash from Pengzhi Venture Capital and Ms. Guan Congqiao, with transfer prices of 3.5 million yuan and 8.75 million yuan, respectively.
According to the announcement, the company focuses on the field of fluorine-containing fine chemicals, while Lansheng Biotechnology has its unique advantages in the fields of pesticide active ingredients and formulations. This joint investment with related parties will help improve the future profitability of the listed company